Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Histamine as a Molecular Transducer of Adaptation to Exercise
NCT05206227Phase 1Active, not recruiting
- Sponsor
- University of Oregon
- Start
- Jul 2021
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Phase 1 trial (4 arms), sponsored by University of Oregon. Primary endpoints: Percentage of mast cell degranulation at 1 hour, Histamine concentration at 1 hour and 2 more. Started Jul 2021; status: active, not recruiting.
Beyond the preview
Go deeper on NCT05206227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05206227.